95MO Tinengotinib in patients with advanced, fibroblast growth factor receptor (FGFR) inhibitor refractory/relapsed cholangiocarcinoma M. Javle, L.A. Kankeu Fonkoua, A. Mahipal,C-Y. Liao, C. Fountzilas,D. Li, M.S. Pelster, S. Goel, P. Peng, C. Sun,H. Wang, K. Hennessy, X. Fu, L. Neo, Y. Shan, P. Huang, D. Wu, F. Wu, J. Fan, S.A. Piha-PaulAnnals of Oncology（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
